Single-Ascending Dose Study of JK07 in Subjects With HFpEF

NCT05322616 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: JK07
DRUG: Matching Placebo

Sponsor

Salubris Biotherapeutics Inc